The Company Bringing Advertising to the Cord-Cutting Generation
It's a new age for advertising. Premion president Jim Wilson joined us at the New York Stock Exchange to discuss how the unit of station-owner TEGNA is capitalizing on the shift to OTT.
Premion says it offers advertisers better control of their ads than traditional tech. "We can literally hand over to our advertisers and let them know exactly where their ads ran," says Wilson, adding that his company is incredibly transparent. The focus for Premion, he says, is brand safety, a big issue nowadays for advertisers.
Wilson also views social media platforms such as Facebook and Twitter as contributing to the fragmentation of the OTT market. Premion incorporates these new competitors into its strategy, as the OTT advertising company continues to scale.
Finally, one of the areas Wilson says Premion is building out is its data management platforms. This is a product Wilson views as comparable to the ones created by Facebook, Google, and other large ad platforms. The company continues to focus on targeting as it builds out its audiences.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
